Serum soluble ST2 is corticosteroid sensitive in asthma
G. E. J. Murphy, M. Spears, I. Donnelly, L. Jolly, J. Thompson, J. Lafferty, E. Cameron, R. Chaudhuri, C. McSharry, M. C. Shepherd, N. C. Thomson (Glasgow, United Kingdom)
Source: Annual Congress 2010 - Asthma: basic science and clinical studies
Session: Asthma: basic science and clinical studies
Session type: Thematic Poster Session
Number: 4308
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. E. J. Murphy, M. Spears, I. Donnelly, L. Jolly, J. Thompson, J. Lafferty, E. Cameron, R. Chaudhuri, C. McSharry, M. C. Shepherd, N. C. Thomson (Glasgow, United Kingdom). Serum soluble ST2 is corticosteroid sensitive in asthma. Eur Respir J 2010; 36: Suppl. 54, 4308
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Serum level of soluble interleukin-2 receptors (sIL-2R) during acute asthma exacerbation, and its relation to severity and response to bronchodilator therapy Source: Eur Respir J 2002; 20: Suppl. 38, 141s Year: 2002
Serum leptin levels in asthmatic children treated with inhaled corticosteroid Source: Eur Respir J 2004; 24: Suppl. 48, 580s Year: 2004
Elevated serum IgE, oral corticosteroid dependence and IL-17/22 expression in highly neutrophilic asthma Source: Eur Respir J, 54 (5) 1900068; 10.1183/13993003.00068-2019 Year: 2019
The effects of inhaled steroids, leukotriene receptor antagonists and theophylline on induced sputum cell counts, serum and sputum ECP levels in mild persistent asthma Source: Eur Respir J 2001; 18: Suppl. 33, 261s Year: 2001
Serum levels of interleukin-18 in patients affected by allergic bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 30s Year: 2002
Serum YKL-40 modulation in severe asthma patients treated with Mepolizumab Source: Virtual Congress 2020 – Monoclonal antibodies in asthma Year: 2020
Serum surfactant protein D (SP-D) is a lung derived biomarker for COPD that is responsive to treatment with oral corticosteroids Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD Year: 2008
Serum levels of IL-8, IL-10 and TNFα in severe allergic asthma Source: Eur Respir J 2005; 26: Suppl. 49, 279s Year: 2005
Correlation between specific serum IgE and exhaled NO levels at low and high inhaled corticosteroid use in allergic asthma Source: Eur Respir J 2005; 26: Suppl. 49, 276s Year: 2005
Serum eosinophil cationic protein as a potential biomarker for interleukin-5 antibody treatment in patients with severe uncontrolled eosinophilic asthma Source: International Congress 2018 – Biomarkers for evaluating asthma Year: 2018
Serum Surfactant Protein D is decreased by oral steroids in asthma but not COPD Source: International Congress 2018 – Clinical determinants of asthma and biomarkers Year: 2018
Effect of montelukast administration on serum IL-5 and total IgE levels in asthmatics Source: Eur Respir J 2004; 24: Suppl. 48, 579s Year: 2004
Influence of inhaled steroids on serum interleukin-5 and interleukin-13 in an adult population of stable asthmatics Source: Eur Respir J 2003; 22: Suppl. 45, 291s Year: 2003
Elevated serum IL-12 and IL-18 levels in patients with bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 424s Year: 2002
Serum TNFα and IL8 as markers of systemic inflammation in severe asthma Source: Eur Respir J 2005; 26: Suppl. 49, 279s Year: 2005
Plasma proteins elevated in severe asthma despite oral steroid use and unrelated to Type-2 inflammation Source: Eur Respir J, 59 (2) 2100142; 10.1183/13993003.00142-2021 Year: 2022
Monitoring free serum IgE in severe asthma patients treated with omalizumab Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD Year: 2011
The effect of montelukast and triamcinolon on clinical parameters and serum levels of ECP, sIL-2R and IL-4 in children with moderate asthma Source: Eur Respir J 2001; 18: Suppl. 33, 123s Year: 2001
Serum high sensitivity C-reactive protein can distinguish cough-variant and bronchial asthma Source: Annual Congress 2008 - New mechanisms in the pathogenesis of asthma and its response to treatment Year: 2008
Monitoring free serum IgE in asthma patients treated with omalizumab Source: Annual Congress 2010 - Asthma: clinical aspects and treatment Year: 2010